At A Glance
Healthcare marketing now runs across mixed-identity conditions, where authenticated data, contextual signals, and aggregated measurement all show up in the same campaign. Pharma brands need infrastructure that keeps DTC and HCP identity separate and still connects fragmented signals across activation, privacy, and measurement. Experian acts as an independent, privacy-first identity, data, and workflow layer for pharma marketers, designed specifically for this operating environment.Originally published in Digiday
Key takeaways
- Pharma campaigns now span environments with very different identity conditions, from strong addressability to contextual only signals, which makes coordination a core infrastructure challenge.
- Privacy and compliance rules require DTC (patient) and HCP (healthcare professional) data to stay in separate, non-overlapping workflows at every stage.
- Experian’s identity and workflow layer governs DTC tokenized matching and HCP deterministic National Provider Identifier (NPI) resolution as two distinct processes, never one merged identity path.
- Partner-enabled measurement connects exposure data to outcomes like script lift and qualified HCP engagement through trusted partners including IQVIA Digital, PurpleLab, and OptimizeRx.
A pharmaceutical brand launching a campaign today might rely on authenticated data in one environment, contextual signals in another, and aggregated measurement somewhere else entirely. That’s the reality of healthcare marketing right now, and most brands are still building the operational model to match it.
In a mixed-identity ecosystem, performance comes from the ability to coordinate multiple signal types across activation, privacy, and measurement workflows. Accuracy and scale depend on knowing which approach fits which environment and having the infrastructure to execute across all of them.
From onboarding to outcomes
Pharma marketing teams need identity workflows that can support accurate audience creation, governed activation, and partner-enabled measurement without combining DTC and HCP identity paths.
Download our pharma marketing playbook to help your team:
- Plan DTC and HCP identity strategies with clearer separation
- Prepare audiences for activation across approved channels and partners
- Evaluate audience quality, usable reach, and governance
Healthcare campaigns run across different signal conditions
Healthcare campaigns now run across environments with very different identity conditions, from fully addressable channels to contextual only placements. Digital advertising has long assumed that better identity leads to better targeting, frequency management, orchestration, and measurement, but healthcare has always operated with more constraints than most categories. Those constraints are becoming impossible to ignore as budgets move into connected TV (CTV), point-of-care, publisher-direct, programmatic and retail media-adjacent environments.
That shift changes the operating model. Marketers now have to manage audience strategy, supply quality and performance across channels that don’t support the same level of addressability, interoperability, or measurement visibility. In some environments, identity is strong and can support targeting and measurement. In others, identity is limited or unavailable, and marketers have to rely on contextual or aggregated signals. Managing across both environments is now a core infrastructure challenge for healthcare marketers, and it’s one that requires a deliberate strategy rather than a channel-by-channel patch.
Privacy risk is a media infrastructure issue
Privacy risk in healthcare marketing now shapes how campaigns get built and run from the ground up, extending well beyond compliance into media infrastructure itself. Tighter privacy and compliance expectations mean audience construction, exposure management, and outcomes analysis all get more complex once tracking is restricted.
Data can’t move freely across partners or workflows, and DTC and HCP data environments need to stay isolated from one another. This is especially true in pharma, where the stakes of a compliance misstep extend well beyond a campaign. This creates a more demanding operating model. Healthcare marketers have to balance identity-based and privacy-forward approaches while maintaining reach, relevance, and accountability. That balance requires governance that’s built into the infrastructure, not layered on top of it after the fact.
Experian acts as an independent, privacy-first identity, data, and workflow layer for pharma marketers, designed specifically for this operating environment:
These workflows are governed separately by design, with governed onboarding connecting fragmented DTC and HCP signals to activation-ready audiences without collapsing the two identity paths.
The mixed-identity playbook starts with matching the approach to the environment
The right mixed-identity approach depends on what each environment can support and what the campaign is needs to achieve. A pharmaceutical team may want more addressability, a publisher may only offer contextual or cohort signals, and a measurement partner may need exposure data, while platforms limit how identifiers can be shared.
Healthcare marketers need an operating model built for multiple identity conditions, with clear rules for how signals can be connected, activated, and measured without increasing privacy or compliance risk. That may include:
Experian’s infrastructure supports all three modes:
The missing layer in pharma marketing. Watch our Q&A
Supply quality is a prerequisite for measurement
Supply quality determines whether measurement in a mixed-identity environment can be trusted. When tracking and addressability vary across channels, advertisers need confidence that impressions ran in the right environments and under the right conditions before they can trust any downstream outcomes.
This is especially true in CTV and programmatic, where campaigns span fragmented supply paths, publishers, devices, and partners. Outcomes like script lift or provider engagement are only meaningful if the underlying exposure is reliable and well understood. In healthcare, this also ties directly to brand suitability and disclosure control. Curated supply, publisher-direct deals and placement-level transparency help campaigns run in appropriate environments and give measurement a more defensible foundation.
Clean rooms and tokenization support this, but their effectiveness depends on governance, interoperability, and whether insights can move cleanly across partners and workflows. Partner-enabled measurement, connecting exposure data to outcomes through trusted partners including IQVIA Digital, PurpleLab, and OptimizeRx, is structured in two steps:
- Link activation and measurement IDs without collapsing them into an open identity environment
- Produce aggregated, defensible outcomes including script lift, qualified HCP engagement, and verified delivery
Mixed-identity is the operating reality, and infrastructure is how you manage it
Mixed-identity is now the operating reality for healthcare marketing, not a temporary phase to work around. Performance depends on working across environments where identity is sometimes strong and sometimes limited by design. Healthcare marketers don’t need to pick a single identity approach and apply it everywhere. Building infrastructure that connects deterministic identity, tokenized matching, and contextual signals, keeping compliance, operational flexibility, and trust intact at every step, is what separates the brands managing this well from the ones still patching it channel by channel.
Talk to our team about your healthcare identity strategy
Whether you’re running DTC, HCP, or both, our team can help you build an infrastructure that works across identity environments. Let’s connect.
About the author
Kevin Dunn
Chief Revenue Officer, Experian
Kevin Dunn joins Experian Marketing Services with more than 20 years of leadership experience across marketing and advertising technology, most recently serving as Senior Vice President of Brands and Agencies at LiveRamp. In that role, he led growth across retail, CPG, travel, hospitality, financial services, and healthcare, overseeing new business, account expansion, and channel partnerships.
Kevin is known for building cohesive, accountable teams and leading with optimism, clarity, and a strong sense of shared purpose. His leadership philosophy centers on empowering people, driving positive outcomes for clients and fostering a culture where teams can grow, take smart risks, and succeed together.
FAQs
Mixed-identity means a healthcare campaign relies on more than one type of signal at once, such as authenticated data in one channel, contextual data in another, and aggregated measurement in a third. Pharma brands increasingly need infrastructure that coordinates all of these signal types together instead of treating each channel as a separate problem.
Experian keeps DTC and HCP identity in distinct, non-overlapping workflows so patient data and healthcare professional data never combine. DTC activation runs on high-fidelity tokenized matching, and HCP activation relies on deterministic National Provider Identifier (NPI) resolution using verified attributes like specialty and practice location.
Supply quality matters because outcomes like script lift or provider engagement only mean something if the underlying ad exposure is reliable. Curated supply, publisher-direct deals, and placement-level transparency give healthcare marketers a more defensible foundation before they trust any downstream measurement result.
Partner-enabled measurement connects exposure data to outcomes through trusted third parties such as IQVIA Digital, PurpleLab, and OptimizeRx, without merging activation and measurement identifiers into one open identity environment. The result is aggregated, defensible outcomes like script lift, qualified HCP engagement, and verified delivery.
Healthcare marketers don’t have to choose one approach over the other, since most campaigns already run across both conditions at the same time. Building infrastructure that connects deterministic identity, tokenized matching, and contextual signals is what allows a campaign to stay compliant while still reaching the right audience.
Latest posts
B2B marketers can now deliver the right message to the right user at the right time across devices and channels NEW YORK, NY–(Marketwired – Jun 1, 2016) – Madison Logic, one of the world’s fastest growing companies dedicated to solving the digital needs of B2B marketers, is partnering with Tapad, the leading provider of unified and now a part of Experian, cross-screen marketing technology solutions. Now business-to-business (B2B) marketers can power targeted advertising and content syndication programs across all channels, including smartphones, computers and tablets. The increasing shift in content consumption across mobile devices makes cross-device identification and attribution a top priority for B2B marketers. The Madison Logic and Tapad partnership gives B2B marketers unprecedented reach and scale with the ability to run always-on, cross-device, account-based marketing programs targeting decision makers who are actively researching similar products and services. “Screens are everywhere and so is the B2B buyer,” said Vin Turk, SVP of Audience Development for Madison Logic. “This partnership allows marketers to harness the power of Madison Logic’s intent data and combine it with Tapad’s cross-device solutions to connect with the most-likely-to-convert prospects with hyper-relevant content wherever and whenever they’re doing their research.” “Relevance is essential to the success of B2B marketers, particularly now, when breaking through the clutter is difficult,” said Dave Fall, COO of Tapad. “This partnership with Madison Logic allows marketers to leverage their existing customers while identifying and reaching new audiences with messaging tailored to every device.” For more information about Madison Logic’s account-based marketing platform, please visit https://www.madisonlogic.com/account-based-marketing/. For more information about Tapad’s cross-platform advertising solutions, please visit https://www.experian.com/marketing/consumer-sync. Contact us today
NEW YORK, June 1, 2016 /PRNewswire/ — Are Traasdahl, CEO and founder of Tapad, the leader in cross-device marketing technology and now a part of Experian, has been named Founder of the Year by the Nordic Startup Awards. The Nordic Startup Awards’ Founder of the Year Award recognizes an individual that has shown exceptional achievements in fundraising, customer growth, financial savvy, and/or leadership throughout the past year. The Nordic Startup Awards evaluates hundreds of players in the startup ecosystem, ranging from investors and founders, to developers and journalists in Denmark, Sweden, Iceland, Norway and Finland. Taking place in two stages, each country selects its nominees for consideration for the regional awards which were held in Iceland on May 31, 2016. Traasdahl is recognized for his continuous investment in Tapad as a whole, as well as his dedication to growing and developing Tapad since founding the company in 2010. He has led Tapad from startup through a steady period of growth resulting in an acquisition by the Telenor Group for $360 million in February 2016. “I am truly honored to be named Founder of the Year by the Nordic Startup Awards, among so many other remarkable leaders in the space,” said Traasdahl. “That said, this has always been a team effort. We started Tapad with the goal of giving employees unprecedented growth opportunities while developing breakthrough solutions for our clients. This is a win for everyone at Tapad who has committed themselves to these principles over the past four-and-a-half years.” Tapad is reinforcing its commitment to fostering entrepreneurship with the launch of their new Propeller Program. Through Propeller, Tapad will host five early-stage companies at Tapad’s New York headquarters for a year to set them up for global expansion. In its inaugural year, the first participants will come from Traasdahl’s native Norway. For more information on the Nordic Startup Awards, please visit: http://www.nordicstartupawards.com. Contact us today
NEW YORK, May 4, 2016 /PRNewswire/ — Tapad, the leader in cross-device marketing technology and now a part of Experian, has been honored with two iMedia ASPY Awards. Announced on May 3rd at the iMedia Summit in Lost Pines, TX, Tapad’s 2016 ASPY Awards include “Best Customer Service” and “Best Mobile Partner.” In 2015, Tapad’s proprietary technology, Tapad Device Graph™, was named “Best New Media Innovation” and Tapad employee Chris Martin was awarded the “Rising Star Award.” The iMedia ASPY Awards – determined exclusively by agency votes – recognize the industry’s top marketing technology, media companies and publishers for outstanding service to agencies. The award for “Best Customer Service” recognizes Tapad’s client services team and their dedication to helping agencies fully understand their consumers’ behavior and achieve the best cross-screen campaign ROI through Tapad’s Campaign Pulse and TV Pulse analytics reporting. The “Best Mobile Partner” win recognizes the abilities of the Tapad Device Graph™ to deliver unified cross-screen solutions for the company’s partners. “We are privileged to have a talented and dynamic group of people on our client services team, and we are honored to be recognized by iMedia Connection and our agency partners,” said Tapad Founder and CEO, Are Traasdahl. “We have always strived to provide the best solutions and the best customer support, so it’s extremely gratifying to be rewarded for our efforts. If our clients and partners are happy, we are happy.” For more information on the iMedia ASPY Awards please visit: http://aspyawards.com. Read the full press release here. Contact us today